## MMC: Marsh & McLennan Companies, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.8% below STRENGTH zone (4.0-10.0%); PEG 1.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (58% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($177.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Banque Pictet & Cie SA Purchases 73,091 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20260102T083921 | Neutral | Relevance: 100%
- Banque Pictet & Cie SA increased its stake in Marsh & McLennan Companies by 32.1% in Q3, acquiring 73,091 additional shares to hold a total of 301,059 shares valued at $60.67 million. Despite this institutional buying, CEO John Q. Doyle sold over 21,000 shares in December, reducing his ownership. Marsh & McLennan reported strong Q3 earnings and revenue, with analysts currently holding a "Hold" consensus rating and a $222.35 price target.

**2. Marsh & McLennan Companies, Inc. $MMC Shares Sold by Dupont Capital Management Corp**
- Source: MarketBeat | 20260102T090813 | Neutral | Relevance: 100%
- Dupont Capital Management Corp significantly reduced its stake in Marsh & McLennan Companies by 20.2% in Q3, selling 9,917 shares. Additionally, CEO John Q. Doyle sold 21,079 shares in December, decreasing his position by 19.38%. Despite these sales, institutional investors own nearly 88% of the stock, and analysts maintain a "Hold" rating with an average target price of $222.35.

**3. Bank Pictet & Cie Europe AG Acquires 58,414 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20260102T085021 | Neutral | Relevance: 100%
- Bank Pictet & Cie Europe AG significantly increased its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC) during the third quarter, adding 58,414 shares to hold a total of 278,615 shares valued at approximately $56.15 million. This move is part of broader institutional interest, with several large financial firms also expanding their holdings in MMC, and institutional investors now owning 87.99% of the company's stock. Despite a recent insider stock sale by CEO John Q. Doyle and a "Hold" consensus rating from analysts, the company reported strong Q3 earnings, beating analyst estimates.

**4. Allspring Global Investments Holdings LLC Has $49.25 Million Position in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20260102T084421 | Neutral | Relevance: 100%
- Allspring Global Investments Holdings LLC significantly increased its stake in Marsh & McLennan Companies (NYSE:MMC) by 37.5% in Q3, holding shares valued at $49.25 million. This comes as CEO John Q. Doyle reduced his ownership by nearly 20% through a recent share sale. Analyst sentiment remains mixed with several price target adjustments, resulting in a consensus "Hold" rating for Marsh & McLennan.

**5. Marsh & McLennan Companies, Inc. $MMC Shares Sold by Ninety One UK Ltd**
- Source: MarketBeat | 20260101T140823 | Neutral | Relevance: 100%
- Ninety One UK Ltd significantly reduced its stake in Marsh & McLennan Companies by 46.7% in Q3, selling over 1.18 million shares but retaining a holding valued at approximately $271.4 million. This comes as CEO John Q. Doyle also sold a portion of his shares. Despite these sales, the company reported strong Q3 earnings, beating estimates with $1.85 EPS and $6.35 billion in revenue, and maintains a "Hold" consensus analyst rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $212 | $0 | 0% |
| 2025-12-04 | Citigroup | $201 | $211 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-04 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 11.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.86 elevated, pricing in significant growth expectations. Forward P/E 17.7x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $89.7B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.86 |
| Forward P/E | 17.7 |
| Current P/E | 19.0 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.4% to -0.8% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 42. Volume at 58% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.78% (CS: 29) | Neutral |
| RSI_14 | 42.2 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.997x | Below |
| vs SMA200 | 0.881x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $182.47
- **Stop Loss:** $177.59 (2.7% risk)
- **Target:** $187.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 295
- **Position Value:** $53,828.65
- **Portfolio %:** 53.83%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*